PHARAONIA Pharmaceuticals

PHARAONIA Pharmaceuticals, established in 1997, is a significant entity within the Pharmaceuticals and Healthcare sectors. The company specializes in the manufacture and marketing of an extensive portfolio, currently comprising over 250 pharmaceutical products, with an additional 50 products undergoing development. This broad range covers diverse therapeutic groups and dosage forms, underscoring the company's commitment to addressing varied medical needs through scientific innovation and robust manufacturing capabilities. Its operations are supported by a dedicated workforce and a strategic focus on quality and efficacy.

With a workforce exceeding 1,000 - 5,000 employees, PHARAONIA Pharmaceuticals operates with significant scale, having launched more than 280 products to date. The company serves clients in over 30 countries, demonstrating a robust international presence and a commitment to global health improvement. Its operations are driven by a focus on science and manufacturing excellence, aiming to improve lives worldwide. Meet PHARAONIA Pharmaceuticals's team to understand the expertise behind their success. The company also maintains a community-oriented work environment, fostering collaboration and employee engagement.

The company's strategic focus on care, science, and manufacturing excellence positions it for continued growth in the global pharmaceutical market. PHARAONIA Pharmaceuticals generates substantial revenue, reported at $396.1M, reflecting its market penetration and product demand. The company's dedication to improving lives through its extensive product offerings and its commitment to scientific advancement are central to its mission. With a presence in Africa and the Middle East, and serving over 30 countries, PHARAONIA Pharmaceuticals is a key contributor to healthcare solutions.